The global sleep disorder treatment drugs market is expected to grow at a significant CAGR during the forecast period. Sleep disorders are becoming more common across the globe, rising stress levels, a growing geriatric population, and increased awareness about various treatment choices for this disease are all likely to drive the market growth. According to the Narcolepsy Network, nearly one out of every 2,000 persons in the US suffers from a sleep disorder, which is contributing to the growth of the market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/sleep-disorder-treatment-drugs-market
The global sleep disorder treatment drugs market is anticipated to grow as the general public and governments become more aware of sleep problems. The growing number of people suffering from a variety of sleep disorders, including hallucinations, sleep paralysis, interrupted nocturnal sleep, insomnia, sleep apnea, narcolepsy, and circadian abnormalities, has drawn the attention of governments across the globe, pushing them to take action. Various networks, such as the National Center for Sleep Disorders Research, have run awareness campaigns to address the needs of those with serious or mild sleep disorders.
Additionally, key market players approval by government authority such as the FDA and commercialization of new drugs are also contributing to driving the market growth during the forecast period. For an instance, In March 2019, Sunosi (solriamfetol) was approved by the US Food and Drug Administration for the treatment of narcoleptic patients. However, a lower diagnosis rate, a lower treatment rate, and the adverse effects of sleep disorder medications may hinder demand for sleep disorder treatment drugs.
Among the application segment, insomnia is expected to dominate the global sleep disorders treatment market. The attributable factor for the growth of the segment is an increase in the prevalence of insomnia, which causes severe, uncontrollable daytime sleepiness as well as a loss of muscle tone. According to the National Institutes of Health, nearly 30% of the general population has sleep disruption, with approximately 10% experiencing daily functional impairment compatible with the diagnosis of insomnia. The factors expected to fuel this segment’s growth during the forecast period include increased knowledge of the disease and available treatment choices, which will lead to early diagnosis of the condition.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Takeda Pharmaceutical Co., Ltd., Merck & Co., Inc., and Mylan NV, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Sleep Disorder Treatment Drugs Market Report by Segment
By Drug Type
- Benzodiazepines
- Nonbenzodiazepines
- Antidepressants
- Other
By Application
- Insomnia
- Sleep Apnea
- Narcolepsy
- Circadian Disorders
- Others
A full report of Sleep Disorder Treatment Drugs Market is available at: https://www.omrglobal.com/industry-reports/sleep-disorder-treatment-drugs-market
Sleep Disorder Treatment Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Takeda Pharmaceutical Co., Ltd.
- Merck & Co., Inc.
- Mylan NV
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
